Literature DB >> 15557516

A novel candidate region for ALS on chromosome 14q11.2.

M J Greenway1, M D Alexander, S Ennis, B J Traynor, B Corr, E Frost, A Green, O Hardiman.   

Abstract

Sequence variations with biologic effect in ALS have been identified in the gene for vascular endothelial growth factor (VEGF). The gene for a related protein, angiogenin, lies on chromosome 14q11.2. Analysis of the angiogenin (ANG) gene in the authors' population has demonstrated a significant allelic association with the rs11701 single nucleotide polymorphism (SNP) and identified a novel mutation in two individuals with sporadic ALS that potentially inhibits angiogenin function. These observations propose a candidate region for ALS on chromosome 14q11.2 and suggest that other genes with similar function to VEGF may be important in the pathogenesis of ALS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557516     DOI: 10.1212/01.wnl.0000144344.39103.f6

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  66 in total

1.  A neuroprotective role for angiogenin in models of Parkinson's disease.

Authors:  Trent U Steidinger; David G Standaert; Talene A Yacoubian
Journal:  J Neurochem       Date:  2010-12-22       Impact factor: 5.372

2.  Rare Angiogenin and Ribonuclease 4 variants associated with amyotrophic lateral sclerosis exhibit loss-of-function: a comprehensive in silico study.

Authors:  Aditya K Padhi; Priyam Narain; James Gomes
Journal:  Metab Brain Dis       Date:  2019-07-31       Impact factor: 3.584

Review 3.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Authors:  Shuping Li; Jinghao Sheng; Jamie K Hu; Wenhao Yu; Hiroko Kishikawa; Miaofen G Hu; Kaori Shima; David Wu; Zhengping Xu; Winnie Xin; Katherine B Sims; John E Landers; Robert H Brown; Guo-fu Hu
Journal:  Angiogenesis       Date:  2012-11-10       Impact factor: 9.596

Review 5.  Lack of association between the Angiogenin (ANG) rs11701 polymorphism and amyotrophic lateral sclerosis risk: a meta-analysis.

Authors:  Li-Shou Pan; Xin-Bo Deng; Zheng Wang; Hui-Lin Leng; Xue-Peng Zhu; Dan Ding
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

6.  Association between the Angiogenin (ANG) K17I variant and amyotrophic lateral sclerosis risk in Caucasian: a meta-analysis.

Authors:  Lishou Pan; Xinbo Deng; Dan Ding; Huilin Leng; Xuepeng Zhu; Zheng Wang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

Review 7.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

Review 8.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

9.  Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis.

Authors:  Qiuying Sha; Zhaogong Zhang; Jennifer C Schymick; Bryan J Traynor; Shuanglin Zhang
Journal:  BMC Med Genet       Date:  2009-09-09       Impact factor: 2.103

10.  Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.

Authors:  Rubén Fernández-Santiago; Sabine Hoenig; Peter Lichtner; Anne-Dorte Sperfeld; Manu Sharma; Daniela Berg; Oliver Weichenrieder; Thomas Illig; Katharina Eger; Thomas Meyer; Johanna Anneser; Christoph Münch; Stephan Zierz; Thomas Gasser; Albert Ludolph
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.